BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33124467)

  • 1. Design and synthesis of novel quinic acid derivatives:
    Murugesan A; Holmstedt S; Brown KC; Koivuporras A; Macedo AS; Nguyen N; Fonte P; Rijo P; Yli-Harja O; Candeias NR; Kandhavelu M
    Future Med Chem; 2020 Nov; 12(21):1891-1910. PubMed ID: 33124467
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
    Szeliga M; Karpińska M; Rola R; Niewiadomy A
    Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decane-1,2-diol derivatives as potential antitumor agents for the treatment of glioblastoma.
    Viswanathan A; Zhurina A; Assoah B; Paakkunainen A; Musa A; Kute D; Saravanan KM; Yli-Harja O; Candeias NR; Kandhavelu M
    Eur J Pharmacol; 2018 Oct; 837():105-116. PubMed ID: 30179612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins.
    Xu J; Lee SS; Seo H; Pang L; Jun Y; Zhang RY; Zhang ZY; Kim P; Lee W; Kron SJ; Yeo Y
    Small; 2018 Dec; 14(50):e1803601. PubMed ID: 30411856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
    Liu XX; Yang YT; Wang X; Wang KY; Liu JQ; Lei L; Luo XM; Zhai R; Fu FH; Wang HB; Bi Y
    Eur J Med Chem; 2017 Dec; 141():427-439. PubMed ID: 29040953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of diosgenin derivatives as apoptosis inducers through mitochondria-related pathways.
    Ma L; Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2021 May; 217():113361. PubMed ID: 33740546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro anti-glioblastoma activity of L-valine derived boroxazolidones.
    Viswanathan A; Sebastianelli G; Brown K; Raunio J; Sipilä V; Yli-Harja O; Candeias NR; Kandhavelu M
    Eur J Pharmacol; 2019 Jul; 854():194-200. PubMed ID: 30981767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alkylator anti-glioblastoma agents induced cell cycle G2/M arrest and apoptosis: Design, in silico physicochemical and SAR studies of 2-aminoquinoline-3-carboxamides.
    Yuan P; Gu X; Ni X; Qi Y; Shao X; Xu X; Liu J; Qian X
    Bioorg Med Chem Lett; 2021 Nov; 51():128371. PubMed ID: 34534673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
    Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
    Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line.
    Andrade P; Fraga Dias A; Figueiró F; Torres FC; Kawano DF; Oliveira Battastini AM; Carvalho I; Tomich de Paula da Silva CH; Campos JM
    Future Med Chem; 2020 Apr; 12(8):689-708. PubMed ID: 32193951
    [No Abstract]   [Full Text] [Related]  

  • 14. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells.
    da Silva VD; de Faria BM; Colombo E; Ascari L; Freitas GPA; Flores LS; Cordeiro Y; Romão L; Buarque CD
    Bioorg Chem; 2019 Mar; 83():87-97. PubMed ID: 30343205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
    Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
    Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment.
    Nguyen P; Doan P; Rimpilainen T; Konda Mani S; Murugesan A; Yli-Harja O; Candeias NR; Kandhavelu M
    J Med Chem; 2021 Aug; 64(15):10908-10918. PubMed ID: 34304559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells.
    Hazane-Puch F; Arnaud J; Trocmé C; Faure P; Laporte F; Champelovier P
    Anticancer Agents Med Chem; 2016; 16(4):490-500. PubMed ID: 26286659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
    Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
    Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.